Alper, H. and G. Stephanopoulos, (2007). “Global transcription machinery engineering: a new approach for improving cellular phenotype.” Metabolic Engineering, 9(3): 258-267.

Andersen, D.C. and L. Krummen, (2002). “Recombinant protein expression for therapeutic applications.” Current Opinion in Biotechnology, 13(2): 117-123.

Baeshen, M.N., Al-Hejin, A. M., Bora, R. S., Ahmed, M., Ramadan, H., Saini, K. S., Baeshen, N. A. and E. M. Redwan, (2015). “Production of biopharmaceuticals in E. coli: current scenario and future perspectives.” Journal of Microbiology and Biotechnology, 25(7): 953-962.

Berkmen, M., (2012). “Production of disulfide-bonded proteins in Escherichia coli.” Protein Expression and Purification, 82(1): 240-251.

Biswal, J. K., Ranjan, R. and B. Pattnaik, (2016). “Diagnostic application of recombinant non-structural protein 3A to detect antibodies induced by foot-and-mouth disease virus infection.” Biologicals, 44(3): 157-162.

Bolanos-Garcia, V. M. and O. R. Davies, (2006). “Structural analysis and classification of native proteins from E. coli commonly co-purified by immobilised metal affinity chromatography.” Biochimica et Biophysica Acta (BBA)-General Subjects, 1760(9): 1304-1313.

Burgess-Brown, N. A., Sharma, S., Sobott, F., Loenarz, C., Oppermann, U. and O. Gileadi, (2008). “Codon optimization can improve expression of human genes in Escherichia coli: A multi-gene study.” Protein Expression and Purification, 59(1): 94-102.

Dai, M. and S. D. Copley, (2004). “Genome shuffling improves degradation of the anthropogenic pesticide pentachlorophenol by Sphingobium chlorophenolicum ATCC 39723.” Applied and Environmental Microbiology, 70(4): 2391-2397.

De Marco, A., (2009). “Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.” Microbial Cell Factories, 8(1): 26.

Gąciarz, A., Khatri, N. K., Velez-Suberbie, M. L., Saaranen, M. J., Uchida, Y., Keshavarz-Moore, E. and L. W. Ruddock, (2017). “Efficient soluble expression of disulfide bonded proteins in the cytoplasm of Escherichia coli in fed-batch fermentations on chemically defined minimal media.” Microbial Cell Factories, 16(1): 108.

Ghavim, M., Abnous, K., Arasteh, F., Taghavi, S., Nabavinia, M. S., Alibolandi, M. and M. Ramezani, (2017). “High level expression of recombinant human growth hormone in Escherichia coli: crucial role of translation initiation region.” Research in Pharmaceutical Sciences, 12(2): 168.

Gopal, G. J. and A. Kumar, (2013). “Strategies for the production of recombinant protein in Escherichia coli.” The Protein Journal, 32(6):

-425.

Hartl, F. U., Bracher, A. and M. Hayer-Hartl, (2011). “Molecular chaperones in protein folding and proteostasis.” Nature, 475(7356): 324.

Jia, B. and C. O. Jeon, (2016). “High-throughput recombinant protein expression in Escherichia coli: current status and future perspectives.”Open Biology, 6(8): 160196.

Kapust, R.B. and D. S. Waugh, (1999). “Escherichia coli maltosebinding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused.” Protein Science, 8(8): 1668-1674.

Kim, Y. E., Hipp, M. S., Bracher, A., Hayer-Hartl, M. and F. Ulrich Hartl, (2013). “Molecular chaperone functions in protein folding and proteostasis.” Annual Review of Biochemistry, 82: 323-355.

Kleber-Janke, T. and W.-M. Becker, (2000). “Use of modified BL21 (DE3) Escherichia coli cells for high-level expression of recombinant peanut allergens affected by poor codon usage.” Protein Expression and Purification, 19(3): 419-424.

Klein-Marcuschamer, D., Santos, C. N. S., Yu, H. and G. Stephanopoulos, (2009). “Mutagenesis of the bacterial RNA polymerase alpha subunit for improvement of complex phenotypes.” Applied and Environmental Microbiology, 75(9): 2705-2711.

Lee, J. Y., Sung, B. H., Yu, B. J., Lee, J. H., Lee, S. H., Kim, M. S., Koob, M. D. and S. C. Kim, (2008). “Phenotypic engineering by reprogramming gene transcription using novel artificial transcription factors in Escherichia coli.” Nucleic Acids Research, 36(16): e102.

Löffler, M., Simen, J. D., Jäger, G., Schäferhoff, K., Freund, A. and R. Takors, (2016). “Engineering E. coli for large-scale production– strategies considering ATP expenses and transcriptional responses.” Metabolic Engineering, 38: 73-85.

Lopez, P. J., Marchand, I., Joyce, S. A. and M. Dreyfus, (1999). “The C-terminal half of RNase E, which organizes the Escherichia coli degradosome, participates in mRNA degradation but not rRNA processing in vivo.” Molecular Microbiology, 33(1): 188-199.

Makino, T., Skretas, G. and G. Georgiou, (2011). “Strain engineering for improved expression of recombinant proteins in bacteria.” Microbial Cell Factories, 10(1): 32.

Makino, T., Skretas, G., Kang, T.H. and G. Georgiou, (2011). “Comprehensive engineering of Escherichia coli for enhanced expression of IgG antibodies.” Metabolic Engineering, 13(2): 241-251.

Marschall, L., Sagmeister, P. and C. Herwig, (2017). “Tunable recombinant protein expression in E. coli: promoter systems and genetic constraints.” Applied Microbiology and Biotechnology, 101(2): 501-512.

Massey-Gendel, E., Zhao, A., Boulting, G., Kim, H. Y., Balamotis, M. A., Seligman, L. M., Nakamoto, R. K. and J. U. Bowie, (2009). “Genetic selection system for improving recombinant membrane protein expression in E. coli.” Protein Science, 18(2): 372-383.

Mauro, V. P., (2018). “Codon Optimization in the Production of Recombinant Biotherapeutics: Potential Risks and Considerations.” BioDrugs,:32(1):69-81.

Miroux, B. and J. E. Walker, (1996). Over-production of proteins inEscherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels, Journal of Molecular Biology, 260(3): 289-298.

Park, K.S., Jang, Y.S., Lee, H. and J.S. Kim, (2005). “Phenotypic alteration and target gene identification using combinatorial libraries of zinc finger proteins in prokaryotic cells.” Journal of Bacteriology, 187(15): 5496-5499.

Park, K.S., Lee, D.k., Lee, H., Lee, Y., Jang, Y.S., Kim, Y. H., Yang, H.Y., Lee, S.I., Seol, W. and J.S. Kim, (2003). “Phenotypic alteration of eukaryotic cells using randomized libraries of artificial transcription factors.” Nature Biotechnology, 21(10): 1208.

Patnaik, R., Louie, S., Gavrilovic, V., Perry, K., Stemmer, W. P., Ryan, C. M. and S. del Cardayré, (2002). “Genome shuffling of Lactobacillus for improved acid tolerance.” Nature Biotechnology, 20(7): 707.

Pryor, K. D. and B. Leiting, (1997). “High-Level Expression of Soluble Protein inEscherichia coliUsing a His6-Tag and Maltose- Binding-Protein Double-Affinity Fusion System.” Protein Expression and Purification, 10(3): 309-319.

Ranjbari, J., Babaeipour, V., Vahidi, H., Moghimi, H., Mofid, M. R., Namvaran, M. M. and S. Jafari, (2015). “Enhanced production of insulin-like growth factor I protein in Escherichia coli by optimization of five key factors.” Iranian Journal of Pharmaceutical Research: IJPR, 14(3): 907.

Robichon, C., Luo, J., Causey, T. B., Benner, J. S. and J. C. Samuelson, (2011). “Engineering Escherichia coli BL21 (DE3) derivative strains to minimize E. coli protein contamination after purification by immobilized metal affinity chromatography.” Applied and Environmental Microbiology, 77(13): 4634-4646.

Samuelson J.C. (2011). ″Recent Developments in Difficult Protein Expression: A Guide to E. coli Strains, Promoters, and Relevant Host Mutations.″ In: Evans, J. T., Xu, M. Q. (eds) Heterologous Gene Expression in E.coli. Methods in Molecular Biology (Methods and Protocols), Humana Press. vol 705: 195-209.

Santos, C. N. S. and G. Stephanopoulos, (2008). “Combinatorial engineering of microbes for optimizing cellular phenotype.” Current Opinion in Chemical Biology, 12(2): 168-176.

Schlegel, S., Löfblom, J., Lee, C., Hjelm, A., Klepsch, M., Strous, M., Drew, D., Slotboom, D. J. and J.W. de Gier, (2012). “Optimizing membrane protein overexpression in the Escherichia coli strain Lemo21 (DE3).” Journal of Molecular Biology, 423(4): 648-659.

Sharp, P. M., Cowe, E., Higgins, D. G., Shields, D. C., Wolfe, K. H. and F. Wright, (1988). “Codon usage patterns in Escherichia coli, Bacillus subtilis, Saccharomyces cerevisiae, Schizosaccharomyces pombe, Drosophila melanogaster and Homo sapiens; a review of the considerable within-species diversity.” Nucleic Acids Research, 16(17):8207-8211.

Skretas, G. and G. Georgiou, (2009). “Genetic analysis of G proteincoupled receptor expression in Escherichia coli: inhibitory role of DnaJ

on the membrane integration of the human central cannabinoid receptor.”

Biotechnology and Bioengineering, 102(2): 357-367.

Stewart, E. J., Åslund, F. and J. Beckwith, (1998). “Disulfide bond formation in the Escherichia coli cytoplasm: an in vivo role reversal for the thioredoxins.” The EMBO Journal, 17(19): 5543-5550.

Tegel, H., Tourle, S., Ottosson, J. and A. Persson, (2010). “Increased levels of recombinant human proteins with the Escherichia coli strain Rosetta (DE3).” Protein Expression and Purification, 69(2): 159-167.

Warner, J. R., Reeder, P. J., Karimpour-Fard, A., Woodruff, L. B. and R. T. Gill, (2010). “Rapid profiling of a microbial genome using mixtures of barcoded oligonucleotides.” Nature Biotechnology, 28(8): 856.

Wegerer, A., Sun, T. and J. Altenbuchner, (2008). “Optimization of an E. coli L-rhamnose-inducible expression vector: test of various genetic module combinations.” BMC Biotechnology, 8(1): 2.

Womack, C. (2011). ″Bypassing Common Obstacles in Protein Expression.″ NEB Expressions, Summer 2011.

Wu, X., Jörnvall, H., Berndt, K. D. and U. Oppermann, (2004). “Codon optimization reveals critical factors for high level expression of two rare codon genes in Escherichia coli: RNA stability and secondary structure but not tRNA abundance.” Biochemical and Biophysical Research Communications, 313(1): 89-96.

Xiong, S., Wang, Y.F., Ren, X.R., Li, B., Zhang, M.Y., Luo, Y., Zhang, L., Xie, Q.L. and K.Y. Su, (2005). “Solubility of disulfide-bonded proteins in the cytoplasm of Escherichia coli and its “oxidizing” mutant.” World Journal of Gastroenterology: WJG, 11(7): 1077.

Yin, J., Li, G., Ren, X. and G. Herrler, (2007). “Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes.” Journal of Biotechnology, 127(3): 335-347.

Zhang, Y.X., Perry, K., Vinci, V. A., Powell, K., Stemmer, W. P. and S. B. del Cardayré, (2002). “Genome shuffling leads to rapid phenotypic improvement in bacteria.” Nature, 415(6872): 644.